Nature Medicine's AI Policy: Same Springer Nature Rules, Higher Stakes for Clinical Authors

The rules are identical across Springer Nature, but the implications aren't. Nature Medicine publishes clinical research that directly influences patient care. This creates three areas where AI use carries risks that don't exist at, say, Nature Physics:

If you use an AI tool to draft text about treatment outcomes, drug efficacy, or clinical recommendations, you're introducing a layer of risk that doesn't exist in basic science writing. LLMs can generate plausible-sounding clinical claims that aren't supported by your data. Nature Medicine's reviewers are clinicians who will catch fabricated or exaggerated clinical language, but the reputational damage of submitting a manuscript with AI-generated clinical claims that don't match your trial results could extend beyond a simple rejection.

Consider this scenario: you feed your Results section into ChatGPT and ask it to "make the clinical implications clearer." The AI rephrases your finding from "a 12% reduction in recurrence at 24 months" to "a clinically meaningful reduction in long-term recurrence." That second phrasing is an interpretive claim your data may not fully support. If that language makes it into the published paper and influences treatment decisions, the consequences go beyond academic integrity.

Many clinical trials involve institutional review board (IRB) oversight that extends to the publication of results. Some IRBs have begun asking whether AI tools were used in analyzing or reporting trial data. If your IRB protocol didn't include AI tool use and you fail to disclose it to Nature Medicine, you could face questions from both the journal and your institution.

This isn't hypothetical. Several major research institutions, including NIH-funded centers, have issued guidance requiring researchers to document AI tool use in all research outputs, including manuscripts. If you're running a federally funded clinical trial, your AI disclosure obligations may extend beyond what Nature Medicine requires.

Never input patient data, clinical records, or identifiable information into AI tools. This violates HIPAA (in the US), GDPR (in the EU), and equivalent regulations worldwide. Nature Medicine's AI policy doesn't explicitly address data privacy in AI prompts, but the journal's broader research ethics requirements do. If your AI use involved feeding patient-level data into ChatGPT or any other cloud-based AI tool, you have a bigger problem than disclosure, you may have a privacy breach.

Nature Medicine follows the same Springer Nature format, but given the clinical context, your disclosure should be more specific than what you'd write for a basic science journal.

Good disclosure for a clinical paper:

"During preparation of this manuscript, the authors used ChatGPT (GPT-4, OpenAI) to improve the readability of the Discussion section. The tool was not used to interpret clinical data, generate statistical analyses, or draft clinical recommendations. All AI-suggested edits were reviewed by the clinical investigators (J.S. and M.K.) who verified that the revised text accurately represented the trial findings. The authors take full responsibility for the content of the published article."

Why this works: It specifies what the AI did, what it didn't do, who reviewed the output, and explicitly confirms that clinical content wasn't AI-generated. For a clinical journal like Nature Medicine, this level of specificity protects both you and the journal.

Inadequate disclosure:

"AI tools assisted with manuscript editing."

This tells the reader nothing about which tools, which sections, or whether clinical content was affected. Nature Medicine's editors would send this back.

If you used AI to help with statistical code, the disclosure should be separate from language editing:

"Statistical analyses were conducted in R (version 4.3.1). The authors used GitHub Copilot to assist with writing the survival analysis scripts. All code was independently verified against manual calculations by the biostatistician (L.C.) before execution."

Nature Medicine takes non-disclosure seriously. Here's the escalation path:

Caught during review: The editor returns the manuscript with a request to add proper AI disclosure. If the reviewer flags AI-generated language in clinical sections and the authors didn't disclose, the editor may desk-reject on ethical grounds.

Caught after acceptance: The editorial office contacts authors to add disclosure before publication. If authors resist, acceptance can be withdrawn.

Caught after publication: This triggers a formal investigation. Options include:

• Published correction adding AI disclosure
• Expression of concern if the scope of AI use is unclear
• Retraction if AI use affected clinical data or conclusions
• COPE referral for systematic non-disclosure

The institutional ripple effect: For clinical researchers, a publication ethics investigation at Nature Medicine can trigger parallel reviews by the researcher's institution, their IRB, and funding agencies. A correction at Nature Medicine for undisclosed AI use in a clinical trial report isn't something you can quietly absorb, it becomes part of the public record.

NEJM is the only one of these four that explicitly requires AI disclosure in both the cover letter and the manuscript body. Nature Medicine technically only requires Methods disclosure, but if you're submitting a high-profile clinical paper, disclosing in both places is a reasonable defensive measure.

For clinical trial reports:

• Don't use AI to interpret your trial results. The conclusions in a clinical paper must come from the investigators who designed and ran the trial.
• If you used AI for any statistical code, have your biostatistician verify every output before submission.
• Document your AI use as you go. Keep a simple log: date, tool, what you asked, what you used.

For review articles and perspectives:

• AI can help organize and synthesize literature, but Nature Medicine's editors expect original analytical insight that AI can't provide.
• If you used AI to screen papers for a systematic review, disclose this in your search methodology section.

For all manuscript types:

• Write the AI disclosure as part of your Methods section during drafting, not as an afterthought.
• Make sure all co-authors review and approve the AI disclosure. Clinical papers often have 10+ co-authors; don't let the disclosure be something only the corresponding author knows about.
• If you're unsure whether something requires disclosure, disclose it. Nature Medicine won't penalize you for over-disclosure.

Before submission checklist:

• [ ] AI tools disclosed in Methods with tool name, version, and use case
• [ ] No AI-generated images in figures or graphical abstract
• [ ] Clinical data and conclusions are human-generated
• [ ] No patient data was input into AI tools
• [ ] All co-authors are aware of AI disclosure
• [ ] IRB considerations addressed if applicable

A Nature Medicine submission readiness check can help you check whether your Nature Medicine submission meets the journal's editorial and ethical standards before you submit.

Comply proactively if:

• You used any AI tool (ChatGPT, Grammarly, Copilot) during manuscript preparation
• The journal requires AI use disclosure in the methods or acknowledgments
• Your institution has its own AI use policy that may be stricter

Less concerned if:

• You used AI only for grammar/spell checking (most journals exempt this)
• The journal does not have a formal AI policy yet
• Your use was limited to literature search or reference management